Literature DB >> 11124442

Quantitative neurohistological features of frontotemporal degeneration.

S E Arnold1, L Y Han, C M Clark, M Grossman, J Q Trojanowski.   

Abstract

Frontotemporal degeneration (FTD) is a neurodegenerative condition that has been principally associated with frontal lobe dementia. In this study, we compared neuropathological abnormalities in frontal, hippocampal, and calcarine cortices from patients assigned a diagnosis of FTD, normal elderly and Alzheimer's disease (AD). Densities of Nissl-stained neurons and lesions which were immunolabeled for tau, beta-amyloid (Abeta), alpha- and beta-synuclein, ubiquitin, glial fibrillary acidic protein (GFAP) and CD68 antigen were determined using computer-assisted, non-biased quantitative microscopy. We found that FTD frontal and hippocampal regions exhibited marked neuron loss, abundant ubiquitin-immunoreactive (ir) dystrophic neurites, GFAP-ir astrocytes, and CD68-ir microglia, while calcarine cortex was spared. No alpha- or beta-synuclein-ir lesions were observed, and neither the density of tau-ir neurofibrillary tangles nor that of Abeta-ir plaques in FTD exceeded normal controls. In addition, there were no neuropathological differences between FTD subjects who presented clinically with a frontal lobe dementia versus an AD-like dementia. These findings indicate that FTD is a category of neurodegnerative dementias with varying clinical presentations that is characterized by the progressive degeneration of select populations of cortical neurons. The molecular neurodegenerative mechanisms that lead to FTD remain to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11124442     DOI: 10.1016/s0197-4580(00)00173-1

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  26 in total

Review 1.  Frontotemporal dementia and tauopathy.

Authors:  Y Yoshiyama; V M Lee; J Q Trojanowski
Journal:  Curr Neurol Neurosci Rep       Date:  2001-09       Impact factor: 5.081

Review 2.  Sortilin and SorLA regulate neuronal sorting of trophic and dementia-linked proteins.

Authors:  Lone Tjener Pallesen; Christian Bjerggaard Vaegter
Journal:  Mol Neurobiol       Date:  2012-04       Impact factor: 5.590

3.  Frontal cortex neuropathology in dementia pugilistica.

Authors:  Tommy Saing; Malcolm Dick; Peter T Nelson; Ronald C Kim; David H Cribbs; Elizabeth Head
Journal:  J Neurotrauma       Date:  2012-04-10       Impact factor: 5.269

4.  Thyroid medication use and subsequent development of dementia of the Alzheimer type.

Authors:  Patrick C Harper; Catherine M Roe
Journal:  J Geriatr Psychiatry Neurol       Date:  2009-08-07       Impact factor: 2.680

Review 5.  Amylin and its G-protein-coupled receptor: A probable pathological process and drug target for Alzheimer's disease.

Authors:  Wei Qiao Qiu
Journal:  Neuroscience       Date:  2017-05-19       Impact factor: 3.590

6.  A progressive translational mouse model of human valosin-containing protein disease: the VCP(R155H/+) mouse.

Authors:  Angèle Nalbandian; Katrina J Llewellyn; Mallikarjun Badadani; Hong Z Yin; Christopher Nguyen; Veeral Katheria; Giles Watts; Jogeshwar Mukherjee; Jouni Vesa; Vincent Caiozzo; Tahseen Mozaffar; John H Weiss; Virginia E Kimonis
Journal:  Muscle Nerve       Date:  2012-11-21       Impact factor: 3.217

7.  Association between in vivo fluorine 18-labeled flutemetamol amyloid positron emission tomography imaging and in vivo cerebral cortical histopathology.

Authors:  David A Wolk; Igor D Grachev; Chris Buckley; Hala Kazi; M Sean Grady; John Q Trojanowski; Roy H Hamilton; Paul Sherwin; Richard McLain; Steven E Arnold
Journal:  Arch Neurol       Date:  2011-07-11

8.  Fluid Biomarkers of Frontotemporal Lobar Degeneration.

Authors:  Emma L van der Ende; John C van Swieten
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  Global gene expression profiling in R155H knock-in murine model of VCP disease.

Authors:  Angèle Nalbandian; Svetlana Ghimbovschi; Zuyi Wang; Susan Knoblach; Katrina J Llewellyn; Jouni Vesa; Eric P Hoffman; Virginia E Kimonis
Journal:  Clin Transl Sci       Date:  2014-11-12       Impact factor: 4.689

Review 10.  Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions.

Authors:  Victor L Villemagne; Vincent Doré; Samantha C Burnham; Colin L Masters; Christopher C Rowe
Journal:  Nat Rev Neurol       Date:  2018-02-16       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.